The Claim
Initiation of semaglutide in adults aged approximately 56.2 years, including those with and without type 2 diabetes, is associated with a 3.8% reduction in body weight over a period of 13 to 24 months, with a 5.1% reduction observed in individuals without diabetes.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Adults taking semaglutide for 13 to 24 months lose an average of 3.8% of their body weight, with those without type 2 diabetes losing 5.1% on average.
See the scientific wording
Initiation of semaglutide in adults aged 56.2 years on average, including those with and without type 2 diabetes, is associated with a 3.8% reduction in body weight over 13 to 24 months, with greater reductions (5.1%) observed in those without diabetes, suggesting a clinically meaningful association between semaglutide use and weight loss in real-world populations.
Semaglutide binds to receptors in the brain that control hunger, making the person feel full sooner and less interested in eating, which causes them to consume fewer calories and lose weight.
What the research says
1 studyPeople who took semaglutide lost a small but meaningful amount of weight — about 4% on average, and even more if they didn’t have diabetes. The study found exactly what the claim says, based on real patient data.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.